Piper Sandler served as investment banker to the Committee, and on its behalf, evaluated strategic alternatives for the AmSurg division, prepared expert testimony on valuation in the event of a contested confirmation hearing, and assisted in the negotiations of plan of reorganization terms for unsecured creditors